Lombard Odier Asset Management (Switzerland)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-101,731
Closed -$2.63M 352
2023
Q1
$2.63M Sell
101,731
-3,169
-3% -$84.8K 0.23% 108
2022
Q4
$2.48M Sell
104,900
-6,920
-6% -$187K 0.2% 105
2022
Q3
$2.83M Sell
111,820
-12,445
-10% -$437K 0.24% 95
2022
Q2
$4.13M Sell
124,265
-5,053
-4% -$215K 0.35% 71
2022
Q1
$9.33M Sell
129,318
-75,221
-37% -$5.42M 0.73% 48
2021
Q4
$18.8M Buy
204,539
+17,264
+9% +$2.06M 1.2% 33
2021
Q3
$23.7M Buy
187,275
+52,356
+39% +$7.62M 1.47% 25
2021
Q2
$22.4M Buy
134,919
+97,470
+260% +$15.8M 1.14% 37
2021
Q1
$6.81M Buy
+37,449
New +$8.69M 0.45% 70

Other funds holding TDOC

Lombard Odier Asset Management (Switzerland)'s TDOC Position: Q2 2023 in Review

Lombard Odier Asset Management (Switzerland) sold out of Teladoc Health (TDOC) in Q2 2023, closing a stake of 101,731 shares — an estimated $2.63M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in TDOC in Q1 2021 and held it in 9 quarters. The position peaked at $23.7M in Q3 2021. 432 funds tracked by Wall St. Rank hold TDOC as of Q2 2023.

  • Lombard Odier Asset Management (Switzerland) reported no remaining Teladoc Health position as of Q2 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 101,731 Teladoc Health shares in Q2 2023, an estimated $2.63M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Teladoc Health in Q1 2021 and held it in 9 quarters.
  • Lombard Odier Asset Management (Switzerland)'s Teladoc Health position peaked at $23.7M in Q3 2021.
  • 432 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2023.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.